INTRACAVERNOSAL PAPAVERINE AND PHENTOLAMINE FOR THE MEDICAL-MANAGEMENT OF ERECTILE DYSFUNCTION IN A GENITOURINARY CLINIC

被引：4

作者：

ARMSTRONG, DKB

CONVERY, A

DINSMORE, WW

机构：

[1] Department of Genitourinary Medicine, Royal Victoria Hospital

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 1993年 / 4卷 / 04期

关键词：

ERECTILE DYSFUNCTION; IMPOTENCE; PAPAVERINE; PHENTOLAMINE;

D O I：

10.1177/095646249300400407

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A total of 160 men with erectile failure received treatment with 13 030 intracavernosal papaverine and phentolamine injections as outpatients. One-hundred-and-fifteen (72%) achieved an erection sufficient for sexual intercourse and after a mean follow-up period of 14.1 months, 55 (48%) are still attending and successfully using intracavernous therapy. Sixteen patients had a total of 22 episodes of priapism and one patient developed corporeal fibrosis. We conclude that intracavernous papaverine and phentolamine is an effective therapy for erectile failure in a genitourinary clinic.

引用

页码：214 / 216

页数：3

共 15 条

[1]

Virag R., Intracavernous injection of papaverine for erectile failure, Lancet, ii, (1982)

[2]

Brindley G.S., Cavernosal alpha-blockade: A new technique for investigating and treating erectile impotence, Br J Psychiatry, 143, pp. 332-337, (1983)

[3]

Zorgniotti A.W., Lefleur R.S., Autoinjection of the corpus cavernosus with a vasoactive drug combination for vasculogenic impotence, J Urol, 133, pp. 39-41, (1985)

[4]

Stief C.G., Wetterauer U., Erectile responses to intracavernous papaverine and phentolamine: Comparison of single and combined delivery, J Urol, 140, pp. 1415-1416, (1988)

[5]

Kerfoot W.W., Carson C.C., Pharmacologically induced erection among geriatric men, J Urol, 146, pp. 1022-1024, (1991)

[6]

Sidi A.A., Cameron J.S., Duffy L.M., Intracavernous drug-induced erections in the management of male erectile dysfunction: Experience with 100 patients, J Urol, 135, pp. 704-706, (1986)

[7]

Kiely E.A., Williams G., Goldie L., Assessment of the immediate and short-term effects of pharmacologically induced penile erections in psychogenic and organic impotence, Br J Urol, 59, pp. 164-169, (1987)

[8]

Kartan S., Collins J.P., Mohr D., Double-blind, cross-over study comparing prostaglandin E, and papaverine in patients with vasculogenic impotence, Urology, 37, pp. 516-518, (1991)

[9]

Watters G.R., Keogh E.J., Earie C.M., Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs, J Urol, 140, pp. 1417-1419, (1988)

[10]

Levine S.B., Althof S.E., Turner L.A., Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence, J Urol, 141, pp. 54-57, (1989)

← 1 2 →